EUVIMEDEUVIMED entdecken
Crossref

Orthogonal CRISPR/Cas system facilitated dual-color fluorescence fiber-embedded optofluidic nano-biochip for parallel amplification-free on-site detection of bacterium and virus

Dan Song, Wenjuan Xu, Yuxin Zhuo, Anna Zhu, Feng Long

Microchimica Acta · 2025

DOI: 10.1007/s00604-025-07289-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Dan Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Environment and Natural Resources, Renmin University of China, Beijing, 100872, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Escherichia coli O157, SARS-CoV-2, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial and viral co-infections significantly exacerbate morbidity and mortality. Rapid, sensitive, and parallel detection of these pathogens remains a critical challenge. Here, an orthogonal CRISPR/Cas system facilitated dual-color fluorescence fiber-embedded optofluidic nano-biochip (CD-FOB) was fabricated. Leveraging the time-resolved effect, the CD-FOB achieved ultrasensitive parallel detection of Escherichia coli O157:H7 (E. coli O157:H7) and SARS-CoV-2 based on a multiple signal enhancement strategy, including the collateral cleavage activity of CRISPR/Cas, evanescent wave fluorescence enhancement, DNA-mediated signal amplification, and air-displacement fluorescence enhancement. Without the need for amplification, the CD-FOB system has a detection limit of 643 CFU/mL for E. coli O157:H7 and 3.48 copies/μL for SARS-CoV-2 within 50 min analysis time. To enable rapid on-site detection, a lyophilized CRISPR/Cas assay was prepared using stabilized freeze-dried reagents for detecting E. coli O157:H7 and SARS-CoV-2 in actual samples, achieving recoveries ranging from 70.5% to 200.5%. The unique combination of technical simplicity, multiplexing capability, and operational robustness positions CD-FOB as a versatile solution for combating current and future pathogen threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsEscherichia coli O157SARS-CoV-2Lab-On-A-Chip DevicesLimit of DetectionCOVID-19HumansOptical FibersFluorescenceBiosensing Techniques

Stichwörter der Autor:innen

Escherichia coli O157:H7Dual color fluorescence systemFiber embedded optofluidic nanochipOrthogonal CRISPR/Cas systemSARS-CoV-2

Autor:innen und Institutionen

  • School of Environment and Natural Resources, Renmin University of China, Beijing, 100872, China.
  • School of Environment, Tsinghua University, Beijing, 100084, China.
  • State Key Laboratory of NBC Protection for Civilian, Beijing, 102205, China.
  • School of Environment and Natural Resources, Renmin University of China, Beijing, 100872, China. longf04@ruc.edu.cn.

Förderung

  • Natural Science Foundation of Beijing
  • National Key R&D Program of China

Zitieren

APA

Song, D., Xu, W., Zhuo, Y., Zhu, A., & Long, F. (2025). Orthogonal CRISPR/Cas system facilitated dual-color fluorescence fiber-embedded optofluidic nano-biochip for parallel amplification-free on-site detection of bacterium and virus. Microchimica Acta. https://doi.org/10.1007/s00604-025-07289-5

Vancouver

Song D, Xu W, Zhuo Y, Zhu A, Long F. Orthogonal CRISPR/Cas system facilitated dual-color fluorescence fiber-embedded optofluidic nano-biochip for parallel amplification-free on-site detection of bacterium and virus. Microchimica Acta. 2025. doi:10.1007/s00604-025-07289-5

BibTeX
@article{Song2025,
  author = {Song, Dan and Xu, Wenjuan and Zhuo, Yuxin and Zhu, Anna and Long, Feng},
  title = {Orthogonal CRISPR/Cas system facilitated dual-color fluorescence fiber-embedded optofluidic nano-biochip for parallel amplification-free on-site detection of bacterium and virus},
  journal = {Microchimica Acta},
  year = {2025},
  doi = {10.1007/s00604-025-07289-5}
}
Kostenlos starten →